Clinical Trial Update: Pharmacokinetics of Inhaled Levosimendan [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update describing the pharmacokinetics of inhaled levosimendan for left ventricular dysfunction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Left Ventricular Dysfunction

Drugs mentioned

• Levosimendan (levosimendan)

Snippet

Sponsor: Universitair Ziekenhuis Brussel | Conditions: Left Ventricular Dysfunction | Phase 2 | Status: UNKNOWN